Toward therapeutic effects evaluation of chronic myeloid leukemia drug: Electrochemical platform for caspase-3 activity sensing

Biosensors and Bioelectronics

Volumn 61, Issue , 2014, Pages 648-654

  Zhou, Shiwei ^a   Zheng, Tingting ^a   Chen, Yangfan ^a   Zhang, Jingjing ^a   Li, Linting ^a   Lu, Feng ^a   Zhu, Jun Jie ^a  

^a NANJING UNIVERSITY   (China)

Author keywords

Alkaline phosphatase; Caspase 3; Chronic myeloid leukemia; Dasatinib; Electrochemical biosensor; TRAIL

Indexed keywords

CELL DEATH; CHLORINE COMPOUNDS; COENZYMES; GLASS MEMBRANE ELECTRODES; GOLD; NANOSENSORS; PHOSPHATASES; PROTEINS; VOLTAMMETRY;

ALKALINE PHOSPHATASE; CASPASE-3; CHRONIC MYELOID LEUKEMIAS; DASATINIB; ELECTROCHEMICAL BIOSENSOR; TRAIL;

DISEASES;

ASCORBIC ACID; ASPARTIC ACID; BIOTIN; CARBON NANOTUBE; CASPASE 3; CYSTEINE; DASATINIB; GLUTAMINE; GLYCINE; GOLD NANOPARTICLE; NANOMATERIAL; PEPTIDE DERIVATIVE; POLY(DIALLYLDIMETHYLAMMONIUM CHLORIDE); STREPTAVIDIN; THIOL GROUP; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; VALINE; PROTEIN KINASE INHIBITOR; PYRIMIDINE DERIVATIVE; THIAZOLE DERIVATIVE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BIOSENSOR; BIOTINYLATION; CATALYSIS; CHEMICAL BINDING; CHEMICAL INTERACTION; CHRONIC MYELOID LEUKEMIA; DIFFERENTIAL PULSE VOLTAMMETRY; DRUG EFFICACY; ELECTROCHEMICAL ANALYSIS; ENZYME ACTIVITY; HUMAN; HUMAN CELL; MYELOID LEUKEMIA CELL LINE; DEVICES; DRUG EFFECTS; DRUG SCREENING; ENZYMOLOGY; EQUIPMENT DESIGN; GENETIC PROCEDURES; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

APOPTOSIS; BIOSENSING TECHNIQUES; CASPASE 3; CELL LINE, TUMOR; DRUG SCREENING ASSAYS, ANTITUMOR; ELECTROCHEMICAL TECHNIQUES; EQUIPMENT DESIGN; HUMANS; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; PROTEIN KINASE INHIBITORS; PYRIMIDINES; THIAZOLES; TNF-RELATED APOPTOSIS-INDUCING LIGAND;

EID: 84903387266     PISSN: 09565663     EISSN: 18734235     Source Type: Journal    
DOI: 10.1016/j.bios.2014.05.064     Document Type: Article

References (30)

1. Aguilera D.G., Tsimberidou A.M. Ther. Clin. Risk Manage 2009, 5:281-289.
2. Akanda M.R., Aziz M.A., Jo K., Tamilavan V., Hyun M.H., Kim S., Yang H. Anal. Chem. 2011, 83:3926-3933.
3. Belloc F., Belaud-Rotureau M.A., Lavignolle V., Bascans E., Braz-Pereira E., Durrieu F., Lacombe F. Cytometry 2000, 40:151-160.
4. Druker B.J., Sawyers C.L., Capdeville R., Ford J.M., Baccarani M., Goldman J.M. Hematol. Am. Soc. Hematol. Educ. Program 2001, 1:87-112.
5. Emel B.G., Ali U.U., Ferit A., Yusuf B. Ann. Hematol. 2011, 90:1265-1275.
6. Fadeel B., Orrenius S., Zhivotovsky B. Leukemia 2000, 14:1514-1525.
7. Gencer E.B., Ural A.U., Avcu F., Baran Y. Ann. Hematol. 2011, 90:1265-1275.
8. Geng Q., Jiang J.K., Liu X.S. Leukemia Res. 2012, 36:1417-1421.
9. Gurtu V., Kain S.R., Zhang G.H. Anal. Biochem. 1997, 251:98-102.
10. Hennigs J.K., Keller G., Baumann H.J., Honecker F., Kluge S., Bokemeyer C., Brummendorf T.H., Klose H. BMC Pulm. Med. 2011, 11. 10.1186/1471-2466-11-30.
11. Ji C., Amarnath V., Pietenpol J.A., Marnett L.J. Chem. Res. Toxicol. 2001, 14:1090-1096.
12. Lee H.W., Lee S.H., Lee H.W., Ryu Y.W., Kwon M.H., Kim Y.S. Biochem. Biophys. Res. Commun. 2005, 330:1205-1212.
13. Martinez M.M., Reif R.D., Pappas D. Anal. Methods 2010, 2:996-1004.
14. Mitsiades C.S., Treon S.P., Mitsiades N., Shima Y., Richardson P., Schlossman R., Hideshima T., Anderson K.C. Blood 2001, 98:795-804.
15. Moore E.J., Pravda M., Kreuzer M.P., Guilbault G.G. Anal. Lett. 2003, 36:303-315.
16. Peng B., Hayes M., Resta D., Racine-Poon A., Druker B.J., Talpaz M., Sawyers C.L., Rosamilia M., Ford J., Lloyd P., Capdeville R. J. Clin. Oncol. 2004, 22:935-942.
17. Preechaworapun A., Dai Z., Xiang Y., Chailapakul O., Wang J. Talanta 2008, 76:424-431.
18. Sano M., Saotome M., Urushida T., Katoh H., Satoh H., Ohlishi K., Hayashi H. Internal Med. 2012, 51:2337-2340.
19. Shah N.P. Hematol. Am. Soc. Hematol. Educ. Program 2007, 371-375.
20. Shankar S., Srivastava R.K. Drug Resist. Updat 2004, 7:139-156.
21. Shi J.J., He T.T., Jiang F., Abdel-Halim E.S., Zhu J.J. Biosens. Bioelectron. 2014, 55:51-56.
22. Spencer S.L., Gaudet S., Albeck J.G., Burke J.M., Sorger P.K. Nature 2009, 459:428-432.
23. Xiao H., Liu L., Meng F.B., Huang J.Y., Li G.X. Anal. Chem. 2008, 80:5272-5275.
24. Wang S. Oncogene 2008, 27:6207-6215.
25. Younes A., Aggarwall B.B. Cancer 2003, 98:458-467.
26. Zhang J.J., Cheng F.F., Zheng T.T., Zhu J.J. Anal. Chem. 2010, 82:3547-3555.
27. Zhang J.J., Zheng T.T., Cheng F.F., Zhang J.R., Zhu J.J. Anal. Chem. 2011, 83:7902-7909.
28. Zhang J.J., Zheng T.T., Cheng F.F., Zhu J.J. Chem. Commun. 2011, 47:1147-1180.
29. Zhang S.S., Zhong H., Ding C.F. Anal. Chem. 2008, 80:7206-7212.
30. Zheng T.T., Fu J.J., Hu L.H., Fan Q., Hu M.J., Zhu J.J., Hua Z.C., Wang H. Anal. Chem. 2013, 85:5609-5616.